Thursday, July 16, 2009

Global Congress on Comparator Studies

This is a reminder that the Global Congress on Comparator Studies conference kicks off on Monday in Philadelphia. There is still time to register if you’re interested in integrating a comprehensive blueprint for your comparator studies. Get your comparator studies up to standards before the new administration mandates it.

A selection of confirmed attendees:
Allergan Inc * Almac Clinical Services * Bernstein CMC Regulatory Consulting * Celgene * Cerexa Inc * Eli Lilly & Co * Facet Biotech Corporation * Farma Mondo SA * GlaxoSmithKline * Hospira Inc * Human Genome Sciences Inc * Merck & Company Inc * Multipharma Inc * Mylan Pharmaceuticals Inc * Myoderm Medical * Pfizer * Schering Plough Corporation * Takeda Pharmaceuticals North America Inc * Wyeth Pharmaceuticals

Global Congress on Comparator Studies 2009 is offering a terrific three day conference to amalgamate with industry thought leaders, network with colleagues and develop relationships with industry professionals. Join us to hear insight into how industry leaders are minimizing operational, regulatory and financial risks.


Share this article with your social network, just click below to share now!


No comments :

Post a Comment